Leuprorelin acetate Prescribing at TELDOC
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
322
Total Quantity
322
NHS Cost
£54.6K
vs National Avg
+594.8%
TELDOC prescribed 322 items of Leuprorelin acetate over the last 12 months at a cost of £54,644 to the NHS. This is 594.8% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
29
Jun 2026
27
Jun 2026
31
Jun 2026
31
Jun 2026
20
Jun 2026
38
Jun 2026
25
Jun 2026
27
Jun 2026
22
Jun 2026
25
Jun 2026
22
Jun 2026
25
Prescribing Details
| Total Items | 322 |
|---|---|
| Total Quantity | 322 |
| Total NHS Cost | £54,644 |
| Presentations | 4 different forms |
| vs National Average | +594.8% |
Leuprorelin acetate Prescribing Comparison
| This practice | 322 items |
|---|---|
| National average per practice | 46 items |
| Difference | +594.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.